Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study

Table 4 Comparison of SDQ component scores according to the presence of HIV-related neuroimaging abnormalities (NA).

SDQ Component Score		HIV patients without NA (n = 15)	p-value	HIV patients with NA (n = 5)	p-value	Control group (n = 40)
Emotional	Mean ± SD*	3.4 ± 2.3	0.073^†	2.2 ± 1.1	0.822^†	2.4 ± 1.7
	Normal	12 (80.0%)		5 (100.0%)		38 (95.0%)
	Borderline	1 (6.7%)		0 (0.0%)		2 (5.0%)
	Abnormal	2 (13.3%)	0.047^‡	0 (0.0%)	0.788^‡	0 (0.0%)
Conduct	Mean ± SD*	1.7 ± 1.5	0.533^†	2.6 ± 0.9	0.255^†	2.0 ± 1.2
	Normal	13 (86.7%)		4 (80.0%)		35 (87.5%)
	Borderline	1 (6.7%)		1 (20.0%)		4 (10.0%)
	Abnormal	1 (6.7%)	0.838^‡	0 (0.0%)	0.529^‡	1 (2.5%)
Hyperactivity	Mean ± SD*	4.3 ± 2.9	0.071^†	2.6 ± 1.7	0.503^†	3.1 ± 1.6
	Normal	10 (66.7%)		5 (100.0%)		38 (95.0%)
	Borderline	2 (13.3%)		0 (0.0%)		1 (2.5%)
	Abnormal	3 (20.0%)	0.009^‡	0 (0.0%)	0.788^‡	1 (2.5%)
Peer Problems	Mean ± SD*	2.5 ± 1.6	0.600^†	2.2 ± 2.4	0.941^†	2.2 ± 1.3
	Normal	14 (93.3%)		4 (80.0%)		38 (95.0%)
	Borderline	1 (6.7%)		0 (0.0%)		2 (5.0%)
	Abnormal	0 (0.0%)	0.587^‡	1 (20.0%)	0.033^‡	0 (0.0%)
Prosocial	Mean ± SD*	8.5 ± 1.6	0.630^†	8.6 ± 1.9	0.699^†	8.3 ± 1.6
	Normal	14 (93.3%)		5 (100.0%)		36 (90.0%)
	Borderline	1 (6.7%)		0 (0.0%)		3 (7.5%)
	Abnormal	0 (0.0%)	0.921^‡	0 (0.0%)	0.613^‡	1 (2.5%)
Total Score	Mean ± SD*	11.7 ± 6.6	0.120^†	9.6 ± 2.6	0.769^†	9.1 ± 3.6
	Normal	11 (73.3%)		5 (100.0%)		39 (97.5%)
	Borderline	1 (6.7%)		0 (0.0%)		1 (2.5%)
	Abnormal	3 (20.0%)	0.007^‡	0 (0.0%)		0 (0.0%)

ISSN: 1471-2431